← All runs · Coder view for P17
Replay LRUN-00017 criteria library
Live recomputation (nothing written): identical hash
- Stored replay hash
cdedba8ce66a3f425ba749cd98268e5f4b479eba97c28777bce3eb30830bf440- Recomputed replay hash
cdedba8ce66a3f425ba749cd98268e5f4b479eba97c28777bce3eb30830bf440- Measurement-side replay hash
9cde71da1a1a884ef85b9931901c18d0aac48dbe5043a90948d2f0c8fee95ce5- Inputs intact
- yes
- Engine and default set
- library-engine 1.0 · library_default_set@1.0
- Trigger
- seed · Fri Nov 13, 2026 04:55 PM · after kidney check RUN-00017
| Definition | File sha256 |
|---|---|
ada2026_diabetes@1.0 | e6a402d238eabf94… |
ada2026_hypoglycaemia@1.0 | 46bd77ec8ba977e0… |
ada2026_prediabetes@1.0 | af2c23fe63c64897… |
aha2018_severe_hypercholesterolaemia@1.0 | 07ac207b49ba33e7… |
atp3_ldl@1.0 | 984f30f535df92c4… |
berlin2012_ards_pf@1.0 | f6d9be0dcd8cd4f8… |
cdc_adult_bmi@1.0 | 14a2ac45496eea31… |
esc2024_office_bp@1.0 | f507c6c22d66becc… |
ese2014_hyponatraemia@1.0 | 80cb82e9b02b3fc8… |
global2024_ards_intubated_pf@1.0 | 64bbc3f7fa5c4c0c… |
gold2026_copd_airflow@1.0 | 5fe646eb07866c22… |
nhlbi_bp_categories@1.0 | 17c10323497aaed9… |
sepsis3_septic_shock_lactate@1.0 | 349d2d1b41e02f6a… |
uhf2021_hf_ef_category@1.0 | d056531cd58ff1c1… |
ukka2026_hyperkalaemia@1.0 | 52e59d35a9e19548… |
who1994_osteoporosis@1.0 | 285f666b9d1cbe75… |
who2020_iron_deficiency_ferritin@1.0 | 1cf50051fb66f445… |
who2024_anaemia@1.0 | f2ece42ed4d73490… |
who_adult_bmi@1.0 | de4e41b72636521d… |
Stored inputs (exactly what the definitions read)
{
"as_of": "2026-11-13T16:55:00-05:00",
"context": {},
"encounter": {
"admit_dt": "2026-11-12T11:00:00-05:00",
"discharge_dt": "2026-11-12T11:40:00-05:00",
"encounter_id": "KE-P17",
"setting": "outpatient"
},
"entered": [
{
"code": "E11.9",
"description": "DM2",
"dx_id": "KD-P17-L1",
"source": "encounter diagnosis list"
},
{
"code": "N18.32",
"description": "CKD 3b",
"dx_id": "KD-P17-L2",
"source": "encounter diagnosis list"
}
],
"measurements": [
{
"analyte": "hba1c",
"flags": [],
"measurement_id": "LM-P17-01",
"ref_high": null,
"ref_low": null,
"time": "2026-07-15T09:00:00-04:00",
"unit": "%",
"value": 7.1
},
{
"analyte": "hba1c",
"flags": [],
"measurement_id": "LM-P17-02",
"ref_high": null,
"ref_low": null,
"time": "2026-11-12T10:05:00-05:00",
"unit": "%",
"value": 7.4
}
],
"note": {
"note_id": "KN-P17-1",
"reading": {
"default_status": "silent",
"families": {
"blood_pressure": {
"faults": [],
"spans": [],
"status": "silent"
},
"bmi": {
"faults": [],
"spans": [],
"status": "silent"
},
"bone_density": {
"faults": [],
"spans": [],
"status": "silent"
},
"copd_airflow": {
"faults": [],
"spans": [],
"status": "silent"
},
"diabetes": {
"faults": [],
"spans": [
{
"assertion": "affirmed",
"categories": [],
"end": 8,
"family": "diabetes",
"general": true,
"origin": "both",
"quote": "Diabetes",
"start": 0,
"words": []
},
{
"assertion": "affirmed",
"categories": [],
"end": 113,
"family": "diabetes",
"general": true,
"origin": "both",
"quote": "DM2",
"start": 110,
"words": []
}
],
"status": "stated"
},
"ferritin": {
"faults": [],
"spans": [],
"status": "silent"
},
"haemoglobin": {
"faults": [],
"spans": [],
"status": "silent"
},
"heart_failure_ef": {
"faults": [],
"spans": [],
"status": "silent"
},
"hypoglycaemia": {
"faults": [],
"spans": [],
"status": "silent"
},
"lactate": {
"faults": [],
"spans": [],
"status": "silent"
},
"ldl": {
"faults": [],
"spans": [],
"status": "silent"
},
"oxygenation": {
"faults": [],
"spans": [],
"status": "silent"
},
"potassium": {
"faults": [],
"spans": [],
"status": "silent"
},
"prediabetes": {
"faults": [],
"spans": [],
"status": "silent"
},
"sodium": {
"faults": [],
"spans": [],
"status": "silent"
}
},
"lexicon": "library-lexicon 1.0",
"model_status": "ok",
"reader": "lexicon+model",
"text_sha256": "9928e89b212c2d4f91d241a8d0a5efc5472aa4be75c3efc8a79f3bad752d1c9c"
}
},
"patient": {
"birth_date": "1962-11-17",
"patient_id": "P17",
"sex": "M"
},
"settings": {
"ctcae_grading": false
}
}Stored output
{
"coder_rows": [
{
"assessment": "supported_specific",
"assessment_label": "Supported and specific",
"category": "confirmed",
"category_label": "Diabetes criteria met: two abnormal results (different tests, or the same test at two times)",
"condition": "Diabetes mellitus",
"definition": "ada2026_diabetes@1.0",
"detail": "",
"entered": [
{
"code": "E11.9",
"description": "DM2",
"dx_id": "KD-P17-L1",
"source": "encounter diagnosis list"
}
],
"expected_codes": [],
"family": "diabetes",
"note": {
"mentions": [
{
"assertion": "affirmed",
"quote": "Diabetes"
},
{
"assertion": "affirmed",
"quote": "DM2"
}
],
"quotes": [
"Diabetes",
"DM2"
],
"status": "stated"
},
"open": false,
"query_available": false,
"reasons": [],
"specificity_distinguished": "type 2 diabetes with or without complications by body system (kidney, eye, nerve, circulatory, skin, oral, hypoglycaemia, hyperglycaemia, ketoacidosis, hyperosmolarity), long-term drug use is separate (Z79)",
"state": "met",
"supported": {
"category": "confirmed",
"earlier": false,
"time": "2026-11-13T16:55:00-05:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P17-02",
"time": "2026-11-12T10:05:00-05:00",
"unit": "%",
"value": 7.4
}
]
},
"tier": "measured",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P17-02",
"time": "2026-11-12T10:05:00-05:00",
"unit": "%",
"value": 7.4
}
]
},
{
"assessment": "no_action",
"assessment_label": "Nothing to act on",
"category": "diabetes_range",
"category_label": "A result is in the diabetes range \u2014 prediabetes not assigned; see ada2026_diabetes",
"condition": "Prediabetes",
"definition": "ada2026_prediabetes@1.0",
"detail": "",
"entered": [],
"expected_codes": [],
"family": "prediabetes",
"note": {
"mentions": [],
"quotes": [],
"status": "silent"
},
"open": false,
"query_available": false,
"reasons": [],
"specificity_distinguished": null,
"state": "not_met",
"supported": null,
"tier": "measured",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P17-02",
"time": "2026-11-12T10:05:00-05:00",
"unit": "%",
"value": 7.4
}
]
}
],
"config": "library_default_set@1.0",
"definitions": {
"ada2026_diabetes@1.0": "e6a402d238eabf948e24e0c1a768094b2a8eab1534d0208b533bcf624a7c56a7",
"ada2026_hypoglycaemia@1.0": "46bd77ec8ba977e0a1f201d4ef02d934accd0ab454ed12ef6d6c7f189f56a9a0",
"ada2026_prediabetes@1.0": "af2c23fe63c64897f2f72242153b81971f32dba4ad55ac279abf2a2991d0e112",
"aha2018_severe_hypercholesterolaemia@1.0": "07ac207b49ba33e7c341f45bd1e6652460273e35b8ccb6e9882ce4e14506f24b",
"atp3_ldl@1.0": "984f30f535df92c4f68bcb7331a079e98e17980f6cba9e3e3ca40f3dda5eee03",
"berlin2012_ards_pf@1.0": "f6d9be0dcd8cd4f86bcc8ecd1bd12854e408cc9e25db8f136564584b9c202d77",
"cdc_adult_bmi@1.0": "14a2ac45496eea318a30ab4841e1635efe3b8051355ff920c39b471475a3fa80",
"esc2024_office_bp@1.0": "f507c6c22d66beccef76705f376bfcd942d7852733727916e8e70c9b78ef9f4c",
"ese2014_hyponatraemia@1.0": "80cb82e9b02b3fc8c2af10544ac52733b115d2a2436f871ddd9f56276c4fd90b",
"global2024_ards_intubated_pf@1.0": "64bbc3f7fa5c4c0c445d87883b20d22351bdb59ba670062bb4807a1bc924b89f",
"gold2026_copd_airflow@1.0": "5fe646eb07866c220b55269655e680c559148e99cda65c6dd5faf3198d549e93",
"nhlbi_bp_categories@1.0": "17c10323497aaed97bf08b4f9db27dc328068eccd4fd0fccf11af416207b76d3",
"sepsis3_septic_shock_lactate@1.0": "349d2d1b41e02f6a8ad26bd1df917967ec1b78539948f165c14d29e427e8d6aa",
"uhf2021_hf_ef_category@1.0": "d056531cd58ff1c18dba497a2ed8f8373ed9f9583c3a072a8b525d6a67eb61c3",
"ukka2026_hyperkalaemia@1.0": "52e59d35a9e19548932d6bf551f322dbcd68e1e05aab0ba68e346d81eaf35c73",
"who1994_osteoporosis@1.0": "285f666b9d1cbe759d9b827772316840002f5b2439b71ed10aedcb437a089014",
"who2020_iron_deficiency_ferritin@1.0": "1cf50051fb66f445ab663519fb2ec6e5d60dc73f96a9ee96a86becd424e10ad1",
"who2024_anaemia@1.0": "f2ece42ed4d7349094e3066f58b4bd9aece49873b33aa458945093e29ad4cede",
"who_adult_bmi@1.0": "de4e41b72636521df138a3846f673cb8d1f1bb3695ace4d31b592352a719668e"
},
"engine": "library-engine 1.0",
"findings": [
{
"checks": [
"contradiction",
"specificity"
],
"citation": {
"code_reference": {
"categories": [
{
"billable_codes_fy2027": 87,
"category": "E11",
"cms_hcc_v28": {
"codes_mapping": 76,
"hccs": [
"36",
"37",
"38",
"263",
"298",
"383"
]
},
"ms_drg_v44": {
"codes_with_cc": 1,
"codes_with_mcc": 5,
"summary": "5 MCC and 1 CC codes"
},
"note": "Type of diabetes must be documented; E10 (type 1), E08/E09/E13 (other types) are parallel categories.",
"source": "data/code_reference_fy2027.json (CDC/NCHS ICD-10-CM FY2027 order file; CMS FY2027 Tables 6I/6J; CMS 2027 Initial ICD-10-CM Mappings)",
"specificity_distinguished": "type 2 diabetes with or without complications by body system (kidney, eye, nerve, circulatory, skin, oral, hypoglycaemia, hyperglycaemia, ketoacidosis, hyperosmolarity), long-term drug use is separate (Z79)",
"title": "Type 2 diabetes mellitus"
},
{
"billable_codes_fy2027": 87,
"category": "E10",
"cms_hcc_v28": {
"codes_mapping": 74,
"hccs": [
"36",
"37",
"38",
"263",
"298",
"383"
]
},
"ms_drg_v44": {
"codes_with_cc": 1,
"codes_with_mcc": 3,
"summary": "3 MCC and 1 CC codes"
},
"note": null,
"source": "data/code_reference_fy2027.json (CDC/NCHS ICD-10-CM FY2027 order file; CMS FY2027 Tables 6I/6J; CMS 2027 Initial ICD-10-CM Mappings)",
"specificity_distinguished": "type 1 diabetes with the same complication axes as E11",
"title": "Type 1 diabetes mellitus"
}
],
"icd10cm_fiscal_year": "FY2027 (effective 2026-10-01)",
"null_reason": null,
"use": "reference for coders \u2014 the software never assigns or suggests a code"
},
"condition": "Diabetes mellitus",
"confirmation": null,
"contested": {
"is_contested": false,
"why": "ADA thresholds match long-standing WHO thresholds for A1C and FPG, but WHO's current text was not opened; the A1C criterion is less sensitive in some populations (ADA text)."
},
"edition": {
"checked_at": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12690183/",
"checked_on": "2026-11-14",
"edition": "Standards of Care in Diabetes\u20142026",
"is_current": true,
"note": "The 2026 Standards (Diabetes Care 2026;49 Suppl 1) are the newest edition indexed (Europe PMC lists 2024, 2025 and 2026 versions of section 2). The publisher site refused automated access (HTTP 403); the PubMed Central copy was read.",
"year": 2026
},
"id": "ada2026_diabetes",
"inputs": [
{
"analyte": "hba1c",
"key": "a1c",
"select": "latest",
"source_units": [
"%",
"mmol/mol"
],
"unit": "%"
},
{
"analyte": "glucose_fasting_plasma",
"key": "fpg",
"select": "latest",
"source_units": [
"mg/dL",
"mmol/L"
],
"unit": "mg/dL"
},
{
"analyte": "glucose_ogtt_2h_plasma",
"key": "ogtt",
"select": "latest",
"source_units": [
"mg/dL",
"mmol/L"
],
"unit": "mg/dL"
},
{
"analyte": "glucose_random_plasma",
"key": "rpg",
"select": "highest",
"source_units": [
"mg/dL",
"mmol/L"
],
"unit": "mg/dL"
}
],
"interpretation_notes": [
"Each A1C, fasting glucose and 2-h OGTT measurement at or above its threshold counts as one abnormal result; two results at the same time from different tests count as two (ADA: 'may be obtained at the same time (e.g., A1C and FPG)'); the same test twice counts only at two different times (records with identical analyte and time are one record).",
"A random glucose \u2265200 mg/dL counts only with classic symptoms or crisis and is not counted towards the two-result rule.",
"ADA prints both units for each threshold; each unit is compared against its own printed number (48 mmol/mol, 7.0 mmol/L, 11.1 mmol/L)."
],
"kind": "executable definition",
"not_encoded": [
"Type of diabetes (type 1, type 2, other) is not assessed.",
"Conditions that make A1C unreliable (some haemoglobin variants, pregnancy, G6PD deficiency, HIV, anaemia, haemodialysis, erythropoietin; recommendation 2.4 and text) are not checked: A1C results are used as sent.",
"No maximum interval between the two abnormal results is stated by the source and none is applied.",
"Whether the test method is NGSP-certified and whether a fasting sample was truly fasting are asserted by the sender through the analyte name.",
"When two different tests are discordant ADA advises repeating the abnormal test; this entry simply reports one abnormal result."
],
"population": "non-pregnant individuals (Table 2.1 title: 'in nonpregnant individuals')",
"primary_source": {
"accessed": "2026-11-14",
"body": "American Diabetes Association Professional Practice Committee",
"edition": "2026 (Diabetes Care 2026;49 Suppl 1:S27-S49, doi:10.2337/dc26-S002)",
"locator": "Table 2.1 Criteria for the diagnosis of diabetes in nonpregnant individuals",
"quote": "Table 2.1: A1C \u22656.5% (\u226548 mmol/mol); FPG \u2265126 mg/dL (\u22657.0 mmol/L); 2-h PG \u2265200 mg/dL (\u226511.1 mmol/L) during OGTT; random plasma glucose \u2265200 mg/dL (\u226511.1 mmol/L) with classic symptoms of hyperglycemia or hyperglycemic crisis. In the absence of unequivocal hyperglycemia, diagnosis requires two abnormal results from different tests ... or the same test at two different time points.",
"title": "2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142026",
"url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12690183/",
"year": 2026
},
"second_source": null,
"second_source_note": "The WHO diabetes fact sheet (dated 11 November 2026) states no numeric thresholds; the WHO 2006/2011 reports were not opened. No independent second source was opened.",
"second_source_status": "not found",
"status": "draft \u2014 requires clinical and coding review",
"thresholds": [
{
"categories": [
{
"condition_present": true,
"id": "confirmed",
"label": "Diabetes criteria met: two abnormal results (different tests, or the same test at two times)",
"rule": "number of results meeting [a1c \u2265 6.5 % / 48 mmol/mol; fpg \u2265 126 mg/dL / 7 mmol/L; ogtt \u2265 200 mg/dL / 11.1 mmol/L] \u2265 2"
},
{
"condition_present": true,
"id": "random_with_symptoms",
"label": "Diabetes criteria met: random plasma glucose \u2265200 mg/dL with classic symptoms or crisis",
"rule": "rpg \u2265 200 mg/dL / 11.1 mmol/L and classic_symptoms_or_crisis = True"
},
{
"condition_present": true,
"id": "single_abnormal",
"label": "One abnormal result \u2014 ADA requires a second abnormal result to confirm",
"rule": "number of results meeting [a1c \u2265 6.5 % / 48 mmol/mol; fpg \u2265 126 mg/dL / 7 mmol/L; ogtt \u2265 200 mg/dL / 11.1 mmol/L] \u2265 1"
}
],
"variant": "all",
"variant_label": "all patients in the population"
}
],
"tier": 1,
"title": "Diabetes diagnostic thresholds and the confirmation rule (ADA Standards of Care 2026)",
"version": "1.0"
},
"contested": false,
"contested_note": "ADA thresholds match long-standing WHO thresholds for A1C and FPG, but WHO's current text was not opened; the A1C criterion is less sensitive in some populations (ADA text).",
"definition": "ada2026_diabetes@1.0",
"direction": "CONSISTENT",
"draft": true,
"family": "diabetes",
"family_order": 3,
"id": "ada2026_diabetes",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": true,
"category": "confirmed",
"category_label": "Diabetes criteria met: two abnormal results (different tests, or the same test at two times)",
"clinician_label": "two results at or above the diagnostic thresholds",
"condition_threshold": "two results at or above the diagnostic thresholds (number of qualifying results \u2265 2); random glucose 200 mg/dL or more with typical symptoms (random glucose \u2265 200 mg/dL and a recorded clinical item); one result at or above a diagnostic threshold (number of qualifying results \u2265 1)",
"confirmation": null,
"contested": false,
"contested_note": "ADA thresholds match long-standing WHO thresholds for A1C and FPG, but WHO's current text was not opened; the A1C criterion is less sensitive in some populations (ADA text).",
"definition": "ada2026_diabetes@1.0",
"edition_current": true,
"family": "diabetes",
"has_data": true,
"id": "ada2026_diabetes",
"missing_context": [],
"notes": [],
"reason_code": null,
"reasons": [],
"result": "met",
"scan": [
{
"category": "single_abnormal",
"confirmed": false,
"result": "met",
"time": "2026-07-15T09:00:00-04:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P17-01",
"time": "2026-07-15T09:00:00-04:00",
"unit": "%",
"value": 7.1
}
]
},
{
"category": "confirmed",
"confirmed": true,
"result": "met",
"time": "2026-11-12T10:05:00-05:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P17-02",
"time": "2026-11-12T10:05:00-05:00",
"unit": "%",
"value": 7.4
}
]
}
],
"state": "met",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": {
"category": "confirmed",
"earlier": false,
"time": "2026-11-13T16:55:00-05:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P17-02",
"time": "2026-11-12T10:05:00-05:00",
"unit": "%",
"value": 7.4
}
]
},
"threshold": "number of qualifying results \u2265 2",
"tier": "measured",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P17-02",
"time": "2026-11-12T10:05:00-05:00",
"unit": "%",
"value": 7.4
}
],
"variant": "all",
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 2,
"to": "2026-11-13T21:55:00"
},
"window_assessable": true,
"window_met": true
},
"note": {
"faults": [],
"spans": [
{
"assertion": "affirmed",
"categories": [],
"end": 8,
"family": "diabetes",
"general": true,
"origin": "both",
"quote": "Diabetes",
"start": 0,
"words": []
},
{
"assertion": "affirmed",
"categories": [],
"end": 113,
"family": "diabetes",
"general": true,
"origin": "both",
"quote": "DM2",
"start": 110,
"words": []
}
],
"status": "stated"
},
"optional_set": null,
"priority": [
6,
3,
"diabetes"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Glucose and HbA1c",
"version": "1.0",
"why": ""
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": {
"code_reference": {
"categories": [
{
"billable_codes_fy2027": 5,
"category": "R73",
"cms_hcc_v28": {
"codes_mapping": 0,
"hccs": []
},
"ms_drg_v44": {
"codes_with_cc": 0,
"codes_with_mcc": 0,
"summary": "no code in this category is on the FY2027 CC or MCC list"
},
"note": null,
"source": "data/code_reference_fy2027.json (CDC/NCHS ICD-10-CM FY2027 order file; CMS FY2027 Tables 6I/6J; CMS 2027 Initial ICD-10-CM Mappings)",
"specificity_distinguished": "R73.01 impaired fasting glucose, R73.02 impaired glucose tolerance (oral), R73.03 prediabetes, R73.09 other abnormal glucose, R73.9 hyperglycaemia unspecified",
"title": "Elevated blood glucose level"
}
],
"icd10cm_fiscal_year": "FY2027 (effective 2026-10-01)",
"null_reason": null,
"use": "reference for coders \u2014 the software never assigns or suggests a code"
},
"condition": "Prediabetes",
"confirmation": null,
"contested": {
"is_contested": true,
"why": "Other bodies (for example WHO) are understood to use a different impaired fasting glucose range and not to use an A1C prediabetes range; those texts were not opened, so no other thresholds are recorded. Review item."
},
"edition": {
"checked_at": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12690183/",
"checked_on": "2026-11-14",
"edition": "Standards of Care in Diabetes\u20142026",
"is_current": true,
"note": "The 2026 Standards (Diabetes Care 2026;49 Suppl 1) are the newest edition indexed (Europe PMC lists 2024, 2025 and 2026 versions of section 2). The publisher site refused automated access (HTTP 403); the PubMed Central copy was read.",
"year": 2026
},
"id": "ada2026_prediabetes",
"inputs": [
{
"analyte": "hba1c",
"key": "a1c",
"select": "latest",
"source_units": [
"%",
"mmol/mol"
],
"unit": "%"
},
{
"analyte": "glucose_fasting_plasma",
"key": "fpg",
"select": "latest",
"source_units": [
"mg/dL",
"mmol/L"
],
"unit": "mg/dL"
},
{
"analyte": "glucose_ogtt_2h_plasma",
"key": "ogtt",
"select": "latest",
"source_units": [
"mg/dL",
"mmol/L"
],
"unit": "mg/dL"
}
],
"interpretation_notes": [
"Adjacent printed ranges that differ by one reporting unit (for example '120\u2013129' then '130\u2013139', or '5.5-5.9' then '6.0-6.4') are read as half-open intervals [lower, next lower), so a value between them (129.5, 5.95) falls in the lower band. Only a genuine gap in the printed ranges returns not assessable. A1C '5.7\u20136.4%' is read as [5.7, 6.5) since 6.5% starts the diabetes range; '39\u201347 mmol/mol' as [39, 48); FPG '100 mg/dL (5.6 mmol/L) to 125 mg/dL (6.9 mmol/L)' as [100, 126) mg/dL and [5.6, 7.0) mmol/L; 2-h PG '140 (7.8) to 199 (11.0)' as [140, 200) mg/dL and [7.8, 11.1) mmol/L.",
"If any most-recent result is in the diabetes range the entry reports that and does not assign prediabetes."
],
"kind": "executable definition",
"not_encoded": [
"ADA does not require confirmation for prediabetes in Table 2.2; none is applied.",
"A1C reliability conditions are not checked (see ada2026_diabetes).",
"Only the most recent result of each test is used."
],
"population": "non-pregnant individuals (Table 2.2 title)",
"primary_source": {
"accessed": "2026-11-14",
"body": "American Diabetes Association Professional Practice Committee",
"edition": "2026 (Diabetes Care 2026;49 Suppl 1:S27-S49)",
"locator": "Table 2.2 Criteria defining prediabetes in nonpregnant individuals",
"quote": "A1C 5.7\u20136.4% (39\u201347 mmol/mol); FPG 100 mg/dL (5.6 mmol/L) to 125 mg/dL (6.9 mmol/L) (IFG); 2-h PG during 75-g OGTT 140 mg/dL (7.8 mmol/L) to 199 mg/dL (11.0 mmol/L) (IGT)",
"title": "2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes\u20142026",
"url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC12690183/",
"year": 2026
},
"second_source": null,
"second_source_note": "No independent second source was opened.",
"second_source_status": "not found",
"status": "draft \u2014 requires clinical and coding review",
"thresholds": [
{
"categories": [
{
"condition_present": false,
"id": "diabetes_range",
"label": "A result is in the diabetes range \u2014 prediabetes not assigned; see ada2026_diabetes",
"rule": "a1c \u2265 6.5 % / 48 mmol/mol or fpg \u2265 126 mg/dL / 7 mmol/L or ogtt \u2265 200 mg/dL / 11.1 mmol/L"
},
{
"condition_present": true,
"id": "prediabetes",
"label": "Prediabetes range (A1C 5.7\u20136.4%, IFG 100\u2013125 mg/dL or IGT 140\u2013199 mg/dL)",
"rule": "a1c \u2265 5.7 % / 39 mmol/mol and a1c < 6.5 % / 48 mmol/mol or fpg \u2265 100 mg/dL / 5.6 mmol/L and fpg < 126 mg/dL / 7 mmol/L or ogtt \u2265 140 mg/dL / 7.8 mmol/L and ogtt < 200 mg/dL / 11.1 mmol/L"
}
],
"variant": "all",
"variant_label": "all patients in the population"
}
],
"tier": 1,
"title": "Prediabetes ranges (ADA Standards of Care 2026)",
"version": "1.0"
},
"contested": true,
"contested_note": "Other bodies (for example WHO) are understood to use a different impaired fasting glucose range and not to use an A1C prediabetes range; those texts were not opened, so no other thresholds are recorded. Review item.",
"definition": "ada2026_prediabetes@1.0",
"direction": "NONE",
"draft": true,
"family": "prediabetes",
"family_order": 4,
"id": "ada2026_prediabetes",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": true,
"category": "diabetes_range",
"category_label": "A result is in the diabetes range \u2014 prediabetes not assigned; see ada2026_diabetes",
"clinician_label": "a result in the higher (diagnostic) range",
"condition_threshold": "intermediate range (HbA1c 5.7 to 6.4%, fasting glucose 100 to 125 mg/dL, or 2-hour glucose 140 to 199 mg/dL) (HbA1c \u2265 5.7 % and HbA1c < 6.5 % or fasting glucose \u2265 100 mg/dL and fasting glucose < 126 mg/dL or 2-hour glucose \u2265 140 mg/dL and 2-hour glucose < 200 mg/dL)",
"confirmation": null,
"contested": true,
"contested_note": "Other bodies (for example WHO) are understood to use a different impaired fasting glucose range and not to use an A1C prediabetes range; those texts were not opened, so no other thresholds are recorded. Review item.",
"definition": "ada2026_prediabetes@1.0",
"edition_current": true,
"family": "prediabetes",
"has_data": true,
"id": "ada2026_prediabetes",
"missing_context": [],
"notes": [],
"reason_code": null,
"reasons": [],
"result": "criteria_not_met",
"scan": [
{
"category": "diabetes_range",
"confirmed": true,
"result": "criteria_not_met",
"time": "2026-07-15T09:00:00-04:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P17-01",
"time": "2026-07-15T09:00:00-04:00",
"unit": "%",
"value": 7.1
}
]
},
{
"category": "diabetes_range",
"confirmed": true,
"result": "criteria_not_met",
"time": "2026-11-12T10:05:00-05:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P17-02",
"time": "2026-11-12T10:05:00-05:00",
"unit": "%",
"value": 7.4
}
]
}
],
"state": "not_met",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": "HbA1c \u2265 6.5 % or fasting glucose \u2265 126 mg/dL or 2-hour glucose \u2265 200 mg/dL",
"tier": "measured",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P17-02",
"time": "2026-11-12T10:05:00-05:00",
"unit": "%",
"value": 7.4
}
],
"variant": "all",
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 2,
"to": "2026-11-13T21:55:00"
},
"window_assessable": true,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
7,
4,
"prediabetes"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Glucose and HbA1c (intermediate range)",
"version": "1.0",
"why": ""
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "Cut-offs are 5th percentiles of mostly higher-income populations (WHO's own remark); the men's 130 g/L cut-off and severity percentages were debated by the guideline group; CTCAE and laboratory reference ranges use other limits; older adults (>65) are not covered.",
"definition": "who2024_anaemia@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "haemoglobin",
"family_order": 0,
"id": "who2024_anaemia",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "'severe' band (haemoglobin < 70 g/L); 'moderate' band (haemoglobin \u2265 70 g/L and haemoglobin < 100 g/L); 'mild' band (haemoglobin \u2265 100 g/L and haemoglobin < 110 g/L)",
"confirmation": null,
"contested": true,
"contested_note": "Cut-offs are 5th percentiles of mostly higher-income populations (WHO's own remark); the men's 130 g/L cut-off and severity percentages were debated by the guideline group; CTCAE and laboratory reference ranges use other limits; older adults (>65) are not covered.",
"definition": "who2024_anaemia@1.0",
"edition_current": true,
"family": "haemoglobin",
"has_data": false,
"id": "who2024_anaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable haemoglobin measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 30,
"from": "2026-10-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
0,
"haemoglobin"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Haemoglobin",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": false,
"contested_note": "The <135 mmol/L definition is widely shared; CTCAE uses the laboratory LLN instead.",
"definition": "ese2014_hyponatraemia@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "sodium",
"family_order": 1,
"id": "ese2014_hyponatraemia",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "below 135 mmol/L (sodium < 135 mmol/L)",
"confirmation": null,
"contested": false,
"contested_note": "The <135 mmol/L definition is widely shared; CTCAE uses the laboratory LLN instead.",
"definition": "ese2014_hyponatraemia@1.0",
"edition_current": null,
"family": "sodium",
"has_data": false,
"id": "ese2014_hyponatraemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable sodium_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
1,
"sodium"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Sodium",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "The guideline itself says 'There is no universally accepted definition of hyperkalaemia'; it adopts the ERC threshold of 5.5 mmol/L. CTCAE grades differ (see ctcae6_hyperkalaemia).",
"definition": "ukka2026_hyperkalaemia@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "potassium",
"family_order": 2,
"id": "ukka2026_hyperkalaemia",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "'severe' band (6.5 mmol/L or more) (potassium \u2265 6.5 mmol/L); 'moderate' band (6.0 to 6.4 mmol/L) (potassium \u2265 6 mmol/L and potassium < 6.5 mmol/L); 'mild' band (5.5 to 5.9 mmol/L) (potassium \u2265 5.5 mmol/L and potassium < 6 mmol/L)",
"confirmation": null,
"contested": true,
"contested_note": "The guideline itself says 'There is no universally accepted definition of hyperkalaemia'; it adopts the ERC threshold of 5.5 mmol/L. CTCAE grades differ (see ctcae6_hyperkalaemia).",
"definition": "ukka2026_hyperkalaemia@1.0",
"edition_current": true,
"family": "potassium",
"has_data": false,
"id": "ukka2026_hyperkalaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable potassium_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
2,
"potassium"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Potassium",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "The International Hypoglycaemia Study Group (2017) sets level 1 at 'a glucose alert value of 3.9 mmol/l (70 mg/dl) or less', i.e. it includes exactly 70 mg/dL; ADA 2026 uses '<70'. CTCAE uses other cut-offs.",
"definition": "ada2026_hypoglycaemia@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "hypoglycaemia",
"family_order": 5,
"id": "ada2026_hypoglycaemia",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "level 3 (severe event needing assistance) (a recorded clinical item); level 2 (glucose below 54 mg/dL) (glucose < 54 mg/dL); level 1 (glucose 54 to below 70 mg/dL) (glucose \u2265 54 mg/dL and glucose < 70 mg/dL)",
"confirmation": null,
"contested": true,
"contested_note": "The International Hypoglycaemia Study Group (2017) sets level 1 at 'a glucose alert value of 3.9 mmol/l (70 mg/dl) or less', i.e. it includes exactly 70 mg/dL; ADA 2026 uses '<70'. CTCAE uses other cut-offs.",
"definition": "ada2026_hypoglycaemia@1.0",
"edition_current": true,
"family": "hypoglycaemia",
"has_data": false,
"id": "ada2026_hypoglycaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'has_diabetes' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
5,
"hypoglycaemia"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Low glucose values",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "BMI cut-offs are population-specific (WHO 2004 expert consultation proposed lower action points for Asian populations; not opened) and BMI does not measure adiposity directly; the CDC page applies the categories 'regardless of age, sex, or race' for adults.",
"definition": "cdc_adult_bmi@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "bmi",
"family_order": 6,
"id": "cdc_adult_bmi",
"measurement": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "who_adult_bmi@1.0",
"id": "who_adult_bmi",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no usable bmi measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "40 or more band (class 3) (body-mass index \u2265 40 kg/m2); 35 to below 40 band (class 2) (body-mass index \u2265 35 kg/m2 and body-mass index < 40 kg/m2); 30 to below 35 band (class 1) (body-mass index \u2265 30 kg/m2 and body-mass index < 35 kg/m2); 25 to below 30 band (body-mass index \u2265 25 kg/m2 and body-mass index < 30 kg/m2); below 18.5 band (body-mass index < 18.5 kg/m2)",
"confirmation": null,
"contested": true,
"contested_note": "BMI cut-offs are population-specific (WHO 2004 expert consultation proposed lower action points for Asian populations; not opened) and BMI does not measure adiposity directly; the CDC page applies the categories 'regardless of age, sex, or race' for adults.",
"definition": "cdc_adult_bmi@1.0",
"edition_current": true,
"family": "bmi",
"has_data": false,
"id": "cdc_adult_bmi",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable bmi measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
6,
"bmi"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Body-mass index",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "European guidelines define hypertension at 140/90 (ESC 2024, encoded separately as esc2024_office_bp) while AHA/ACC use 130/80.",
"definition": "nhlbi_bp_categories@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "blood_pressure",
"family_order": 7,
"id": "nhlbi_bp_categories",
"measurement": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "esc2024_office_bp@1.0",
"id": "esc2024_office_bp",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no reading with all of bp_systolic_office, bp_diastolic_office recorded at the same time",
"no usable bp_diastolic_office measurement",
"no usable bp_systolic_office measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "range above 180 systolic or above 120 diastolic (systolic > 180 mmHg or diastolic > 120 mmHg); stage 2 range (140 or more systolic, or 90 or more diastolic) (systolic \u2265 140 mmHg or diastolic \u2265 90 mmHg); stage 1 range (130 to 139 systolic, or 80 to 89 diastolic) (systolic \u2265 130 mmHg and systolic < 140 mmHg or diastolic \u2265 80 mmHg and diastolic < 90 mmHg); elevated range (120 to 129 systolic and below 80 diastolic) (systolic \u2265 120 mmHg and systolic < 130 mmHg and diastolic < 80 mmHg)",
"confirmation": null,
"contested": true,
"contested_note": "European guidelines define hypertension at 140/90 (ESC 2024, encoded separately as esc2024_office_bp) while AHA/ACC use 130/80.",
"definition": "nhlbi_bp_categories@1.0",
"edition_current": true,
"family": "blood_pressure",
"has_data": false,
"id": "nhlbi_bp_categories",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no reading with all of bp_systolic_office, bp_diastolic_office recorded at the same time",
"no usable bp_diastolic_office measurement",
"no usable bp_systolic_office measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
7,
"blood_pressure"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Blood pressure readings",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": false,
"contested_note": "Same 190 mg/dL boundary as ATP III 'very high'.",
"definition": "aha2018_severe_hypercholesterolaemia@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "ldl",
"family_order": 8,
"id": "aha2018_severe_hypercholesterolaemia",
"measurement": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "atp3_ldl@1.0",
"id": "atp3_ldl",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no usable ldl_cholesterol measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "LDL 190 mg/dL or more (LDL \u2265 190 mg/dL)",
"confirmation": null,
"contested": false,
"contested_note": "Same 190 mg/dL boundary as ATP III 'very high'.",
"definition": "aha2018_severe_hypercholesterolaemia@1.0",
"edition_current": true,
"family": "ldl",
"has_data": false,
"id": "aha2018_severe_hypercholesterolaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable ldl_cholesterol measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
8,
"ldl"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "LDL cholesterol",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "Ferritin cut-offs for iron deficiency vary widely between bodies and studies (the guideline's own review cites thresholds from <12 to <30 \u00b5g/L in pregnancy); WHO's are low (high specificity). Other bodies (e.g. gastroenterology guidance) use higher values; those texts were not opened.",
"definition": "who2020_iron_deficiency_ferritin@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "ferritin",
"family_order": 9,
"id": "who2020_iron_deficiency_ferritin",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "band below the ferritin cut-off for this group (ferritin < 15 ug/L)",
"confirmation": null,
"contested": true,
"contested_note": "Ferritin cut-offs for iron deficiency vary widely between bodies and studies (the guideline's own review cites thresholds from <12 to <30 \u00b5g/L in pregnancy); WHO's are low (high specificity). Other bodies (e.g. gastroenterology guidance) use higher values; those texts were not opened.",
"definition": "who2020_iron_deficiency_ferritin@1.0",
"edition_current": true,
"family": "ferritin",
"has_data": false,
"id": "who2020_iron_deficiency_ferritin",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable ferritin_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 180,
"from": "2026-05-17T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
9,
"ferritin"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Ferritin",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"contradiction",
"not_stated"
],
"citation": null,
"contested": true,
"contested_note": "T-score categories were defined for postmenopausal (white) women; their use in men and other populations relies on later bodies (e.g. ISCD), which were not opened; the report itself calls cut-off values 'somewhat arbitrary'.",
"definition": "who1994_osteoporosis@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "bone_density",
"family_order": 10,
"id": "who1994_osteoporosis",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "T-score below -2.5 with a fragility fracture (T-score < -2.5 SD and a recorded clinical item); T-score -2.5 or lower band (T-score \u2264 -2.5 SD); T-score between -1 and -2.5 band (T-score > -2.5 SD and T-score < -1 SD)",
"confirmation": null,
"contested": true,
"contested_note": "T-score categories were defined for postmenopausal (white) women; their use in men and other populations relies on later bodies (e.g. ISCD), which were not opened; the report itself calls cut-off values 'somewhat arbitrary'.",
"definition": "who1994_osteoporosis@1.0",
"edition_current": null,
"family": "bone_density",
"has_data": false,
"id": "who1994_osteoporosis",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"outside the population the source defines: postmenopausal women (the report's categories are stated 'in women' in the context of postmenopausal osteoporosis)"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 1095,
"from": "2023-11-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
10,
"bone_density"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "measured",
"topic": "Bone density T-score",
"version": "1.0",
"why": "no measurement in the window"
},
{
"checks": [
"judgement_tier"
],
"citation": null,
"contested": true,
"contested_note": "The fixed ratio 0.7 is contested against the lower limit of normal (z-score) approach used by ATS/ERS interpretation standards (not opened); the fixed ratio over-diagnoses in older and under-diagnoses in younger adults.",
"definition": "gold2026_copd_airflow@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "copd_airflow",
"family_order": 11,
"id": "gold2026_copd_airflow",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "FEV1/FVC below 0.7 with FEV1 below 30% predicted (grade 4) (FEV1/FVC < 0.7 and FEV1 % predicted < 30 %); FEV1/FVC below 0.7 with FEV1 30 to below 50% predicted (grade 3) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 30 % and FEV1 % predicted < 50 %); FEV1/FVC below 0.7 with FEV1 50 to below 80% predicted (grade 2) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 50 % and FEV1 % predicted < 80 %); FEV1/FVC below 0.7 with FEV1 80% predicted or more (grade 1) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 80 %)",
"confirmation": null,
"contested": true,
"contested_note": "The fixed ratio 0.7 is contested against the lower limit of normal (z-score) approach used by ATS/ERS interpretation standards (not opened); the fixed ratio over-diagnoses in older and under-diagnoses in younger adults.",
"definition": "gold2026_copd_airflow@1.0",
"edition_current": true,
"family": "copd_airflow",
"has_data": false,
"id": "gold2026_copd_airflow",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no reading with all of fev1_fvc_ratio_post_bd, fev1_pct_predicted_post_bd recorded at the same time",
"no usable fev1_fvc_ratio_post_bd measurement",
"no usable fev1_pct_predicted_post_bd measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 1095,
"from": "2023-11-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
11,
"copd_airflow"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "judgement",
"topic": "Lung function after bronchodilator",
"version": "1.0",
"why": ""
},
{
"checks": [
"judgement_tier"
],
"citation": null,
"contested": false,
"contested_note": "The same cut-offs appear in the co-published Eur J Heart Fail and J Card Fail versions; some guidelines describe HFmrEF differently in wording only (not opened).",
"definition": "uhf2021_hf_ef_category@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "heart_failure_ef",
"family_order": 12,
"id": "uhf2021_hf_ef_category",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "improved category (from 40% or below to above 40%, a rise of 10 points or more) (earliest ejection fraction \u2264 40 % and ejection fraction > 40 % and change in ejection fraction \u2265 10); 40% or below (ejection fraction \u2264 40 %); 41 to 49% (ejection fraction > 40 % and ejection fraction < 50 %); 50% or above (ejection fraction \u2265 50 %)",
"confirmation": null,
"contested": false,
"contested_note": "The same cut-offs appear in the co-published Eur J Heart Fail and J Card Fail versions; some guidelines describe HFmrEF differently in wording only (not opened).",
"definition": "uhf2021_hf_ef_category@1.0",
"edition_current": null,
"family": "heart_failure_ef",
"has_data": false,
"id": "uhf2021_hf_ef_category",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'heart_failure' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
12,
"heart_failure_ef"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "judgement",
"topic": "Ejection fraction",
"version": "1.0",
"why": ""
},
{
"checks": [
"judgement_tier"
],
"citation": null,
"contested": false,
"contested_note": "The CMS SEP-1 measure and the Surviving Sepsis Campaign use lactate thresholds for other purposes (for example \u22654 mmol/L); those documents were not opened for this entry.",
"definition": "sepsis3_septic_shock_lactate@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "lactate",
"family_order": 13,
"id": "sepsis3_septic_shock_lactate",
"measurement": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "lactate above 2 mmol/L (lactate > 2 mmol/L)",
"confirmation": null,
"contested": false,
"contested_note": "The CMS SEP-1 measure and the Surviving Sepsis Campaign use lactate thresholds for other purposes (for example \u22654 mmol/L); those documents were not opened for this entry.",
"definition": "sepsis3_septic_shock_lactate@1.0",
"edition_current": true,
"family": "lactate",
"has_data": false,
"id": "sepsis3_septic_shock_lactate",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable lactate_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 7,
"from": "2026-11-06T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
13,
"lactate"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "judgement",
"topic": "Lactate",
"version": "1.0",
"why": ""
},
{
"checks": [
"judgement_tier"
],
"citation": null,
"contested": false,
"contested_note": "Bands unchanged from Berlin for intubated patients.",
"definition": "global2024_ards_intubated_pf@1.0",
"direction": "NOT_ASSESSED",
"draft": true,
"family": "oxygenation",
"family_order": 14,
"id": "global2024_ards_intubated_pf",
"measurement": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "berlin2012_ards_pf@1.0",
"id": "berlin2012_ards_pf",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no reading with all of pao2, fio2 recorded at the same time",
"no usable fio2 measurement",
"no usable pao2 measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "PaO2/FiO2 \u2264 100; PaO2/FiO2 > 100 and PaO2/FiO2 \u2264 200; PaO2/FiO2 > 200 and PaO2/FiO2 \u2264 300",
"confirmation": null,
"contested": false,
"contested_note": "Bands unchanged from Berlin for intubated patients.",
"definition": "global2024_ards_intubated_pf@1.0",
"edition_current": true,
"family": "oxygenation",
"has_data": false,
"id": "global2024_ards_intubated_pf",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'intubated' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 7,
"from": "2026-11-06T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"note": {
"faults": [],
"spans": [],
"status": "silent"
},
"optional_set": null,
"priority": [
8,
14,
"oxygenation"
],
"status_text": "draft \u2014 requires clinical and coding review",
"tier": "judgement",
"topic": "Oxygenation (PaO2/FiO2)",
"version": "1.0",
"why": ""
}
],
"measurement": {
"config": "library_default_set@1.0",
"context_used": {
"age_years": 63,
"sex": "male"
},
"engine": "library-engine 1.0",
"families": {
"blood_pressure": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "esc2024_office_bp@1.0",
"id": "esc2024_office_bp",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no reading with all of bp_systolic_office, bp_diastolic_office recorded at the same time",
"no usable bp_diastolic_office measurement",
"no usable bp_systolic_office measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "range above 180 systolic or above 120 diastolic (systolic > 180 mmHg or diastolic > 120 mmHg); stage 2 range (140 or more systolic, or 90 or more diastolic) (systolic \u2265 140 mmHg or diastolic \u2265 90 mmHg); stage 1 range (130 to 139 systolic, or 80 to 89 diastolic) (systolic \u2265 130 mmHg and systolic < 140 mmHg or diastolic \u2265 80 mmHg and diastolic < 90 mmHg); elevated range (120 to 129 systolic and below 80 diastolic) (systolic \u2265 120 mmHg and systolic < 130 mmHg and diastolic < 80 mmHg)",
"confirmation": null,
"contested": true,
"contested_note": "European guidelines define hypertension at 140/90 (ESC 2024, encoded separately as esc2024_office_bp) while AHA/ACC use 130/80.",
"definition": "nhlbi_bp_categories@1.0",
"edition_current": true,
"family": "blood_pressure",
"has_data": false,
"id": "nhlbi_bp_categories",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no reading with all of bp_systolic_office, bp_diastolic_office recorded at the same time",
"no usable bp_diastolic_office measurement",
"no usable bp_systolic_office measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"bmi": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "who_adult_bmi@1.0",
"id": "who_adult_bmi",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no usable bmi measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "40 or more band (class 3) (body-mass index \u2265 40 kg/m2); 35 to below 40 band (class 2) (body-mass index \u2265 35 kg/m2 and body-mass index < 40 kg/m2); 30 to below 35 band (class 1) (body-mass index \u2265 30 kg/m2 and body-mass index < 35 kg/m2); 25 to below 30 band (body-mass index \u2265 25 kg/m2 and body-mass index < 30 kg/m2); below 18.5 band (body-mass index < 18.5 kg/m2)",
"confirmation": null,
"contested": true,
"contested_note": "BMI cut-offs are population-specific (WHO 2004 expert consultation proposed lower action points for Asian populations; not opened) and BMI does not measure adiposity directly; the CDC page applies the categories 'regardless of age, sex, or race' for adults.",
"definition": "cdc_adult_bmi@1.0",
"edition_current": true,
"family": "bmi",
"has_data": false,
"id": "cdc_adult_bmi",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable bmi measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"bone_density": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "T-score below -2.5 with a fragility fracture (T-score < -2.5 SD and a recorded clinical item); T-score -2.5 or lower band (T-score \u2264 -2.5 SD); T-score between -1 and -2.5 band (T-score > -2.5 SD and T-score < -1 SD)",
"confirmation": null,
"contested": true,
"contested_note": "T-score categories were defined for postmenopausal (white) women; their use in men and other populations relies on later bodies (e.g. ISCD), which were not opened; the report itself calls cut-off values 'somewhat arbitrary'.",
"definition": "who1994_osteoporosis@1.0",
"edition_current": null,
"family": "bone_density",
"has_data": false,
"id": "who1994_osteoporosis",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"outside the population the source defines: postmenopausal women (the report's categories are stated 'in women' in the context of postmenopausal osteoporosis)"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 1095,
"from": "2023-11-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"copd_airflow": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "FEV1/FVC below 0.7 with FEV1 below 30% predicted (grade 4) (FEV1/FVC < 0.7 and FEV1 % predicted < 30 %); FEV1/FVC below 0.7 with FEV1 30 to below 50% predicted (grade 3) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 30 % and FEV1 % predicted < 50 %); FEV1/FVC below 0.7 with FEV1 50 to below 80% predicted (grade 2) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 50 % and FEV1 % predicted < 80 %); FEV1/FVC below 0.7 with FEV1 80% predicted or more (grade 1) (FEV1/FVC < 0.7 and FEV1 % predicted \u2265 80 %)",
"confirmation": null,
"contested": true,
"contested_note": "The fixed ratio 0.7 is contested against the lower limit of normal (z-score) approach used by ATS/ERS interpretation standards (not opened); the fixed ratio over-diagnoses in older and under-diagnoses in younger adults.",
"definition": "gold2026_copd_airflow@1.0",
"edition_current": true,
"family": "copd_airflow",
"has_data": false,
"id": "gold2026_copd_airflow",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no reading with all of fev1_fvc_ratio_post_bd, fev1_pct_predicted_post_bd recorded at the same time",
"no usable fev1_fvc_ratio_post_bd measurement",
"no usable fev1_pct_predicted_post_bd measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 1095,
"from": "2023-11-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"diabetes": {
"adjustments": [],
"alternatives": [],
"any_history": true,
"category": "confirmed",
"category_label": "Diabetes criteria met: two abnormal results (different tests, or the same test at two times)",
"clinician_label": "two results at or above the diagnostic thresholds",
"condition_threshold": "two results at or above the diagnostic thresholds (number of qualifying results \u2265 2); random glucose 200 mg/dL or more with typical symptoms (random glucose \u2265 200 mg/dL and a recorded clinical item); one result at or above a diagnostic threshold (number of qualifying results \u2265 1)",
"confirmation": null,
"contested": false,
"contested_note": "ADA thresholds match long-standing WHO thresholds for A1C and FPG, but WHO's current text was not opened; the A1C criterion is less sensitive in some populations (ADA text).",
"definition": "ada2026_diabetes@1.0",
"edition_current": true,
"family": "diabetes",
"has_data": true,
"id": "ada2026_diabetes",
"missing_context": [],
"notes": [],
"reason_code": null,
"reasons": [],
"result": "met",
"scan": [
{
"category": "single_abnormal",
"confirmed": false,
"result": "met",
"time": "2026-07-15T09:00:00-04:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P17-01",
"time": "2026-07-15T09:00:00-04:00",
"unit": "%",
"value": 7.1
}
]
},
{
"category": "confirmed",
"confirmed": true,
"result": "met",
"time": "2026-11-12T10:05:00-05:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P17-02",
"time": "2026-11-12T10:05:00-05:00",
"unit": "%",
"value": 7.4
}
]
}
],
"state": "met",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": {
"category": "confirmed",
"earlier": false,
"time": "2026-11-13T16:55:00-05:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P17-02",
"time": "2026-11-12T10:05:00-05:00",
"unit": "%",
"value": 7.4
}
]
},
"threshold": "number of qualifying results \u2265 2",
"tier": "measured",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P17-02",
"time": "2026-11-12T10:05:00-05:00",
"unit": "%",
"value": 7.4
}
],
"variant": "all",
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 2,
"to": "2026-11-13T21:55:00"
},
"window_assessable": true,
"window_met": true
},
"ferritin": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "band below the ferritin cut-off for this group (ferritin < 15 ug/L)",
"confirmation": null,
"contested": true,
"contested_note": "Ferritin cut-offs for iron deficiency vary widely between bodies and studies (the guideline's own review cites thresholds from <12 to <30 \u00b5g/L in pregnancy); WHO's are low (high specificity). Other bodies (e.g. gastroenterology guidance) use higher values; those texts were not opened.",
"definition": "who2020_iron_deficiency_ferritin@1.0",
"edition_current": true,
"family": "ferritin",
"has_data": false,
"id": "who2020_iron_deficiency_ferritin",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable ferritin_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 180,
"from": "2026-05-17T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"haemoglobin": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "'severe' band (haemoglobin < 70 g/L); 'moderate' band (haemoglobin \u2265 70 g/L and haemoglobin < 100 g/L); 'mild' band (haemoglobin \u2265 100 g/L and haemoglobin < 110 g/L)",
"confirmation": null,
"contested": true,
"contested_note": "Cut-offs are 5th percentiles of mostly higher-income populations (WHO's own remark); the men's 130 g/L cut-off and severity percentages were debated by the guideline group; CTCAE and laboratory reference ranges use other limits; older adults (>65) are not covered.",
"definition": "who2024_anaemia@1.0",
"edition_current": true,
"family": "haemoglobin",
"has_data": false,
"id": "who2024_anaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable haemoglobin measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 30,
"from": "2026-10-14T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"heart_failure_ef": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "improved category (from 40% or below to above 40%, a rise of 10 points or more) (earliest ejection fraction \u2264 40 % and ejection fraction > 40 % and change in ejection fraction \u2265 10); 40% or below (ejection fraction \u2264 40 %); 41 to 49% (ejection fraction > 40 % and ejection fraction < 50 %); 50% or above (ejection fraction \u2265 50 %)",
"confirmation": null,
"contested": false,
"contested_note": "The same cut-offs appear in the co-published Eur J Heart Fail and J Card Fail versions; some guidelines describe HFmrEF differently in wording only (not opened).",
"definition": "uhf2021_hf_ef_category@1.0",
"edition_current": null,
"family": "heart_failure_ef",
"has_data": false,
"id": "uhf2021_hf_ef_category",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'heart_failure' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"hypoglycaemia": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "level 3 (severe event needing assistance) (a recorded clinical item); level 2 (glucose below 54 mg/dL) (glucose < 54 mg/dL); level 1 (glucose 54 to below 70 mg/dL) (glucose \u2265 54 mg/dL and glucose < 70 mg/dL)",
"confirmation": null,
"contested": true,
"contested_note": "The International Hypoglycaemia Study Group (2017) sets level 1 at 'a glucose alert value of 3.9 mmol/l (70 mg/dl) or less', i.e. it includes exactly 70 mg/dL; ADA 2026 uses '<70'. CTCAE uses other cut-offs.",
"definition": "ada2026_hypoglycaemia@1.0",
"edition_current": true,
"family": "hypoglycaemia",
"has_data": false,
"id": "ada2026_hypoglycaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'has_diabetes' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"lactate": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "lactate above 2 mmol/L (lactate > 2 mmol/L)",
"confirmation": null,
"contested": false,
"contested_note": "The CMS SEP-1 measure and the Surviving Sepsis Campaign use lactate thresholds for other purposes (for example \u22654 mmol/L); those documents were not opened for this entry.",
"definition": "sepsis3_septic_shock_lactate@1.0",
"edition_current": true,
"family": "lactate",
"has_data": false,
"id": "sepsis3_septic_shock_lactate",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable lactate_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 7,
"from": "2026-11-06T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"ldl": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "atp3_ldl@1.0",
"id": "atp3_ldl",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no usable ldl_cholesterol measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "LDL 190 mg/dL or more (LDL \u2265 190 mg/dL)",
"confirmation": null,
"contested": false,
"contested_note": "Same 190 mg/dL boundary as ATP III 'very high'.",
"definition": "aha2018_severe_hypercholesterolaemia@1.0",
"edition_current": true,
"family": "ldl",
"has_data": false,
"id": "aha2018_severe_hypercholesterolaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable ldl_cholesterol measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 730,
"from": "2024-11-13T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"oxygenation": {
"adjustments": [],
"alternatives": [
{
"category": null,
"category_label": null,
"clinician_label": null,
"definition": "berlin2012_ards_pf@1.0",
"id": "berlin2012_ards_pf",
"optional_set": null,
"reason_code": "no_value",
"reasons": [
"no reading with all of pao2, fio2 recorded at the same time",
"no usable fio2 measurement",
"no usable pao2 measurement"
],
"result": "not_assessable",
"version": "1.0"
}
],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "PaO2/FiO2 \u2264 100; PaO2/FiO2 > 100 and PaO2/FiO2 \u2264 200; PaO2/FiO2 > 200 and PaO2/FiO2 \u2264 300",
"confirmation": null,
"contested": false,
"contested_note": "Bands unchanged from Berlin for intubated patients.",
"definition": "global2024_ards_intubated_pf@1.0",
"edition_current": true,
"family": "oxygenation",
"has_data": false,
"id": "global2024_ards_intubated_pf",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"needed to decide whether the definition applies: context 'intubated' not provided"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "judgement",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 7,
"from": "2026-11-06T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"potassium": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "'severe' band (6.5 mmol/L or more) (potassium \u2265 6.5 mmol/L); 'moderate' band (6.0 to 6.4 mmol/L) (potassium \u2265 6 mmol/L and potassium < 6.5 mmol/L); 'mild' band (5.5 to 5.9 mmol/L) (potassium \u2265 5.5 mmol/L and potassium < 6 mmol/L)",
"confirmation": null,
"contested": true,
"contested_note": "The guideline itself says 'There is no universally accepted definition of hyperkalaemia'; it adopts the ERC threshold of 5.5 mmol/L. CTCAE grades differ (see ctcae6_hyperkalaemia).",
"definition": "ukka2026_hyperkalaemia@1.0",
"edition_current": true,
"family": "potassium",
"has_data": false,
"id": "ukka2026_hyperkalaemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable potassium_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
},
"prediabetes": {
"adjustments": [],
"alternatives": [],
"any_history": true,
"category": "diabetes_range",
"category_label": "A result is in the diabetes range \u2014 prediabetes not assigned; see ada2026_diabetes",
"clinician_label": "a result in the higher (diagnostic) range",
"condition_threshold": "intermediate range (HbA1c 5.7 to 6.4%, fasting glucose 100 to 125 mg/dL, or 2-hour glucose 140 to 199 mg/dL) (HbA1c \u2265 5.7 % and HbA1c < 6.5 % or fasting glucose \u2265 100 mg/dL and fasting glucose < 126 mg/dL or 2-hour glucose \u2265 140 mg/dL and 2-hour glucose < 200 mg/dL)",
"confirmation": null,
"contested": true,
"contested_note": "Other bodies (for example WHO) are understood to use a different impaired fasting glucose range and not to use an A1C prediabetes range; those texts were not opened, so no other thresholds are recorded. Review item.",
"definition": "ada2026_prediabetes@1.0",
"edition_current": true,
"family": "prediabetes",
"has_data": true,
"id": "ada2026_prediabetes",
"missing_context": [],
"notes": [],
"reason_code": null,
"reasons": [],
"result": "criteria_not_met",
"scan": [
{
"category": "diabetes_range",
"confirmed": true,
"result": "criteria_not_met",
"time": "2026-07-15T09:00:00-04:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P17-01",
"time": "2026-07-15T09:00:00-04:00",
"unit": "%",
"value": 7.1
}
]
},
{
"category": "diabetes_range",
"confirmed": true,
"result": "criteria_not_met",
"time": "2026-11-12T10:05:00-05:00",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P17-02",
"time": "2026-11-12T10:05:00-05:00",
"unit": "%",
"value": 7.4
}
]
}
],
"state": "not_met",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": "HbA1c \u2265 6.5 % or fasting glucose \u2265 126 mg/dL or 2-hour glucose \u2265 200 mg/dL",
"tier": "measured",
"values": [
{
"analyte": "hba1c",
"measurement_id": "LM-P17-02",
"time": "2026-11-12T10:05:00-05:00",
"unit": "%",
"value": 7.4
}
],
"variant": "all",
"version": "1.0",
"window": {
"days": 365,
"from": "2025-11-13T21:55:00",
"n": 2,
"to": "2026-11-13T21:55:00"
},
"window_assessable": true,
"window_met": false
},
"sodium": {
"adjustments": [],
"alternatives": [],
"any_history": false,
"category": null,
"category_label": null,
"clinician_label": null,
"condition_threshold": "below 135 mmol/L (sodium < 135 mmol/L)",
"confirmation": null,
"contested": false,
"contested_note": "The <135 mmol/L definition is widely shared; CTCAE uses the laboratory LLN instead.",
"definition": "ese2014_hyponatraemia@1.0",
"edition_current": null,
"family": "sodium",
"has_data": false,
"id": "ese2014_hyponatraemia",
"missing_context": [],
"notes": [],
"reason_code": "no_value",
"reasons": [
"no usable sodium_serum measurement"
],
"result": "not_assessable",
"scan": [],
"state": "no_data",
"status_text": "draft \u2014 requires clinical and coding review",
"supported": null,
"threshold": null,
"tier": "measured",
"values": [],
"variant": null,
"version": "1.0",
"window": {
"days": 14,
"from": "2026-10-30T21:55:00",
"n": 0,
"to": "2026-11-13T21:55:00"
},
"window_assessable": false,
"window_met": false
}
}
},
"measurement_sha256": "21bc686675e201d87f037c308c076a97666fe9e6bec80b8a5afac259048eb33e",
"reader": {
"lexicon": "library-lexicon 1.0",
"model_status": "ok",
"reader": "lexicon+model"
}
}